These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32113664)

  • 41. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
    Solomon SD; Vaduganathan M; L Claggett B; Packer M; Zile M; Swedberg K; Rouleau J; A Pfeffer M; Desai A; Lund LH; Kober L; Anand I; Sweitzer N; Linssen G; Merkely B; Luis Arango J; Vinereanu D; Chen CH; Senni M; Sibulo A; Boytsov S; Shi V; Rizkala A; Lefkowitz M; McMurray JJV
    Circulation; 2020 Feb; 141(5):352-361. PubMed ID: 31736342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of heart failure with preserved ejection fraction: Results from the RICA Registry.
    Trullàs JC; Pérez-Calvo JI; Conde-Martel A; Llàcer Iborra P; Suárez Pedreira I; Ormaechea G; Soler Rangel L; González Franco A; Cepeda JM; Montero-Pérez-Barquero M;
    Med Clin (Barc); 2021 Jul; 157(1):1-9. PubMed ID: 32829921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients with atrial fibrillation and mid-range ejection fraction differ in anticoagulation pattern, thrombotic and mortality risk independently of CHA
    Jurin I; Lucijanic M; Jurin H; Starcevic B; Varvodic J; Catic J; Jurisic A; Vitlov P; Sokol Tomic S; Lucijanic J; Hadzibegovic I
    Heart Vessels; 2020 Sep; 35(9):1243-1249. PubMed ID: 32248252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction.
    van Diepen S; Chen AY; Wang TY; Alexander KP; Ezekowitz JA; Peterson ED; Roe MT
    Am Heart J; 2014 Feb; 167(2):267-273.e1. PubMed ID: 24439989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction.
    Dalén M; Lund LH; Ivert T; Holzmann MJ; Sartipy U
    JAMA Cardiol; 2016 Aug; 1(5):530-8. PubMed ID: 27434816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.
    Berry C; Poppe KK; Gamble GD; Earle NJ; Ezekowitz JA; Squire IB; McMurray JJV; McAlister FA; Komajda M; Swedberg K; Maggioni AP; Ahmed A; Whalley GA; Doughty RN; Tarantini L;
    QJM; 2016 Jun; 109(6):377-382. PubMed ID: 25979270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction.
    Shitara J; Naito R; Kasai T; Endo H; Wada H; Doi S; Konishi H; Tsuboi S; Ogita M; Dohi T; Okazaki S; Miyauchi K; Daida H
    BMC Cardiovasc Disord; 2021 Jan; 21(1):36. PubMed ID: 33446110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different Impact of Changes in Left Ventricular Ejection Fraction Between Heart Failure Classifications in Patients With Acute Decompensated Heart Failure.
    Yamamoto M; Seo Y; Ishizu T; Nishi I; Hamada-Harimura Y; Machino-Ohtsuka T; Sato K; Sai S; Nakatsukasa T; Sugano A; Baba M; Obara K; Aonuma K; Ieda M
    Circ J; 2019 Feb; 83(3):584-594. PubMed ID: 30674752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the same.
    Xu L; Pagano JJ; Haykowksy MJ; Ezekowitz JA; Oudit GY; Mikami Y; Howarth A; White JA; Dyck JRB; Anderson T; Paterson DI; Thompson RB;
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):81. PubMed ID: 33267877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction.
    Alkhalil M; Kearney A; MacElhatton D; Fergie R; Dixon L
    Int J Cardiol; 2020 Dec; 321():12-17. PubMed ID: 32682009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Does treatment improve prognosis of heart failure with preserved ejection fraction?].
    Schläpfer-Pessina A; Carballo S; Perrier A; Garin N
    Rev Med Suisse; 2015 Jan; 11(458):199-205. PubMed ID: 25831613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left ventricular fluid dynamics in heart failure: echocardiographic measurement and utilities of vortex formation time.
    Poh KK; Lee LC; Shen L; Chong E; Tan YL; Chai P; Yeo TC; Wood MJ
    Eur Heart J Cardiovasc Imaging; 2012 May; 13(5):385-93. PubMed ID: 22180464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.